Document is current
Any future updates will be listed below
-
Authors
Los, Jonathan
Mensink, Frans B.
Reda Morsy, Mohamed M.
Nishimiya, Kensuke
Oemrawsingh, Rohit M.
IJsselmuiden, Alexander J.J.
Meuwissen, Martijn
Cheng, Jin M.
Rai, Himanshu
ten Cate, Tim J.F
Camaro, Cyril
Damman, Peter
van Nunen, Lokien X.
Dimitriu-Leen, Aukelien C.
van Wely, Marleen H.
Cetinyurek-Yavuz, Aysun
Byrne, Robert A.
van Royen, Niels
van Geuns, Robert-Jan M. https://orcid.org/0000-0003-2943-5932
-
Funding
Funding for this research was provided by:
Amgen Nederland
InfraRedx
Health~Holland
- License Information
-
More Information
Article History
Received: 14 October 2025
Accepted: 1 February 2026
First Online: 23 March 2026
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Dutch Ethical Review Board (METC Oost Nederland).
: Written informed consent was obtained from all individual participants included in the study.
: Mohamed M. Reda Morsy received funding from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) education and training grants program.Kensuke Nishimiya reports research fellowships from Canon Foundation in Europe and the Japanese Grants-in-Aid for Scientific Research (22K08146).Rohit M. Oemrawsingh reports speaker fees from Abbott Vascular and Terumo.Alexander J.J. Ijsselmuiden reports institutional fees from Medtronic, Meril and Abbott and consulting fees from Meril, Angiocare, Abbott, Philips, and Translumina.Cyril Camaro reports institutional speaker fees from Astra Zeneca for regional interventional cardiology meetings.Peter Damman reports research grants from Abbott, Philips, Pie Medical Imaging, and Astra Zeneca and consulting fees from Philips and Abbott.Marleen H. van Wely reports consulting fees from Boston scientific and Abbott vascular.Prof. Robert A. Byrne reports grants received by the institutions of employment for research or education from Abbott Vascular, Biosensors, Boston Scientific, and Translumina without impact on personal remuneration and does not accept personal payments from the medical device or pharmaceutical industry.Prof. van Royen reports research grants from Biotronik, Abbott, Medtronic, and Philips and speaker fees from Abbott, RainMed, Microport, and Bayer.Prof. van Geuns reports consulting and speaker fees from Abbott Vascular and Astra Zeneca. Prof. van Geuns received institutional research grants from Amgen, InfraRedx, Astra Zeneca, and Sanofi.All other authors report no conflicts of interest.
: Radboudumc (sponsor) manages the collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication, with ultimate authority over these activities.
